Study identifies risk for some childhood cancer patients developing secondary leukaemia
Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma – a cancer of immature nerve cells – treatment with platinum chemotherapy caused changes to the genome that could then cause leukaemia in some children later on. The findings, published 27th May 2021 in Blood could lead to…